Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Axsome Therapeutics, Inc. | AXSM | 15.38K | $3.76M |
Protagonist Therapeutics, Inc. | PTGX | 16.3K | $2M |
LB Pharmaceuticals Inc Common Stock | LBRX | 31.79K | $1.03M |
Praxis Precision Medicines, Inc. | PRAX | 37.24K | $12.47M |
Arrowhead Pharmaceuticals, Inc. | ARWR | 39.2K | $3.2M |
Rapport Therapeutics, Inc. Common Stock | RAPP | 66.58K | $2.77M |
Cue Biopharma, Inc. | CUE | 67K | $2.11M |
Cytokinetics, Incorporated | CYTK | 75.6K | $6.44M |
Kodiak Sciences Inc. | KOD | 75.87K | $2.96M |
Xenon Pharmaceuticals Inc. | XENE | 76.08K | $4.59M |
NewAmsterdam Pharma Company N.V. | NAMS | 77.59K | $2.63M |
Pharvaris N.V. | PHVS | 80.91K | $2.8M |
uniQure N.V. | QURE | 88.11K | $4.06M |
Celcuity Inc. | CELC | 98.2K | $10.27M |
Arcutis Biotherapeutics, Inc. | ARQT | 98.94K | $2.59M |
MapLight Therapeutics, Inc. | MPLT | 106.91K | $3.83M |
Spyre Therapeutics, Inc. | SYRE | 106.93K | $9.49M |
Oruka Therapeutics, Inc. | ORKA | 116.46K | $11.08M |
Avalyn Pharma Inc. Common Stock | AVLN | 118K | $3.88M |
Alumis Inc. | ALMS | 135.74K | $3.82M |